24 May 2013
Keywords: norgine, signs, deal, co-market, moviprep, eastern, europe
Article | 23 April 2009
UK-based specialty drugmaker Norgine has signed a deal to co-market Moviprep (NRL994), its product for bowel cleansing before colonoscopy,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com